| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |